Unlock instant, AI-driven research and patent intelligence for your innovation.

Pegylated thrombopoietin mimetic peptide homotetramer and use thereof

A technology of thrombopoietin and PEGylation, which is applied in the field of biotechnology and medicine, can solve the problems of low biological activity, short half-life, and difficult to meet clinical applications.

Active Publication Date: 2019-11-05
CHONGQING PEG BIO BIOTECH CO LTD
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the biological activity of the active peptide of this structure is low in vivo, and the half-life is extremely short, which is difficult to meet the needs of clinical application as a therapeutic drug.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pegylated thrombopoietin mimetic peptide homotetramer and use thereof
  • Pegylated thrombopoietin mimetic peptide homotetramer and use thereof
  • Pegylated thrombopoietin mimetic peptide homotetramer and use thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0034]Example 1, chemical solid-phase synthesis of thrombopoietin mimetic peptide dimer

[0035] The amino acid sequence of the NPC polypeptide is as follows:

[0036] SEQ ID NO: 1 (NPC):

[0037] Cys-Gly-Gly-Gly-Gly-Gly-Ile-Glu-Gly-Pro-Thr-Leu-Arg-Gln-Trp-Leu-Ala-Ala-Arg-Ala-Gly-Gly-Gly-Gly-Gly- Gly-Gly-Gly-Ile-Glu-Gly-Pro-Thr-Leu-Arg-Gln-Trp-Leu-Ala-Ala-Arg-Ala

[0038] When the C-terminus is a carboxyl group, Wang resin is selected for the chemical solid-phase synthesis of the two polypeptides. After the synthesis is completed, the obtained polypeptide resin of the side chain protecting group is cleaved, and the C-terminus of the NPC polypeptide is cleaved from the resin to form a carboxyl group.

[0039] The above solid-phase synthesis was carried out on a peptide synthesizer of ABI Company. First connect the alanine at the C-terminal to the resin, and then carry out amino acids one by one from the C-terminal to the N-terminal. After the synthesis, deprotection group ...

example 2

[0040] Example 2, the recombinant preparation of NPC polypeptide in Escherichia coli

[0041] According to the amino acid sequence of NPC in Example 1, its cDNA sequence was designed using Escherichia coli preferred codons, and the whole gene was artificially synthesized by Dalian Baosheng Biological Company. The synthesized cDNA fragment (inserted into the pMB-19T plasmid) was digested with BamH2 and HindⅢ and recovered, and the recombinant fusion expression pMAL-c2X plasmid was also digested and the large fragment was recovered. Under the action of T4 ligase, the NPC gene fragment and pMAL-c2X were ligated and transformed into DH5α bacteria. The recombinant plasmid containing the inserted NPC gene was screened out and named pMAL-c2X-NPC. Reuse CaCl 2 Transformation expression host strain BL 21 In (DE3), a recombinant expression strain was obtained, which was induced to express the fusion protein of MBP-NPC by 1 mMol / LIPTG. After the fusion protein was purified by Ni-Seph...

example 3

[0046] Example 3, NPC-PEG 20K - Preparation of NPC homotetramer

[0047] Bismaleimide-activated polyethylene glycol (mal-PEG) with an average molecular weight of 20kD 20K -mal) at 20.0mg / ml dissolved in 100mMol / L sodium acetate buffer (pH6.5), under room temperature stirring conditions, gradually add NPC polypeptide until the molar concentration of the two reaches mal-PEG 20K -mal : NPC is 1:2~4. After reacting for 4-12 hours, the PEG-coupled dimer was detected by ELSD (evaporative light) by RP-HPLC to reach more than 85%. Add 1% TFA to terminate the reaction, and use a reverse C18 column to purify and separate unmodified NPC polypeptide and free mal-PEG 20K --mal and single modifier PEG 20K --NPC, purified NPC-PEG 20K --NPC homotetramer was lyophilized into dry powder for storage.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention relates to a preparation method of pegylation thrombopoietin mimic peptide homo-tetramer with a long-acting effect and application of the pegylation thrombopoietin mimic peptide homo-tetramer. The pegylation thrombopoietin mimic peptide homo-tetramer formed by coupling thrombopoietin mimic peptide dimmer with the amino terminal being cysteinyl residues with the two ends of polyethylene glycol molecules has the function of raising the number of peripheral blood platelets in a long-acting mode and can be used as a treatment drug for thrombocytopenia including idiopathic thrombocytopenic purpura, thrombocytopenia caused by chemotherapy, a thrombocytopenia syndrome caused by hepatitis, a myelodysplastic syndrome and the like.

Description

technical field [0001] The invention relates to the preparation and application of a pegylated thrombopoietin mimic peptide homotetramer, belonging to the fields of biotechnology and medicine. Background technique [0002] Thrombocytopenia is a clinically common disease, commonly seen in tumor radiotherapy, chemotherapy and bone marrow transplantation patients, also seen in idiopathic thrombocytopenic purpura (ITP), hepatitis-induced thrombocytopenia syndrome, myelodysplastic syndrome ( MDS) and chronic liver disease. Thrombocytopenia is a common blood disease. After cancer patients receive chemotherapy and radiotherapy, the bone marrow is inhibited to varying degrees, resulting in anemia, neutropenia and thrombocytopenia. Clinically, recombinant long-acting and short-acting EPO and G-CSF have been used to treat anemia and neutropenia, short-acting recombinant IL-11 and TPO are used for thrombocytopenia after radiotherapy and chemotherapy, and long-acting Nplate is used for...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/52A61K38/19A61K47/60A61P7/04
Inventor 陈清范开陈海容
Owner CHONGQING PEG BIO BIOTECH CO LTD